In-depth subtyping of tumor-infiltrating T cells by scRNA-seq revealed a decrease in Tregs and a concurrent increase in effector CD8+ and CD4+ phenotypes, including both Th1 and Th2 subtypes. The gene discussed is CD8A; the disease is neoplasm.